Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nicholas Piramal Considers Taking Partner In R&D Spinoff (India)

This article was originally published in PharmAsia News

Executive Summary

India's Nicholas Piramal is considering a partner when it spins off its research and development arm into a new company later this year. Chairman Ajay Piramal said many investors are interested in being that partner, but the firm has not decided whether to go in that direction. Piramal said the split remains on track and could be completed by May or June if the move gets regulatory approval, as expected, before February. The company currently is developing 13 new chemical entities, including eight now in clinical trials. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts